Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
The Cleveland Clinic Roy Greenberg, MD |
---|---|
Information provided by: | The Cleveland Clinic |
ClinicalTrials.gov Identifier: | NCT00583414 |
The purpose of this study is to assess the role of abdominal aneurysm and iliac aneurysm exclusion using an endovascular prosthesis.
Condition | Intervention | Phase |
---|---|---|
Abdominal Aortic Aneurysm Iliac Aneurysm Hypogastric Aneurysm |
Procedure: Endovascular Repair of Aortic Aneurysm |
Phase I |
Study Type: | Interventional |
Study Design: | Treatment, Open Label, Single Group Assignment, Safety Study |
Official Title: | Endovascular Exclusion of Abdominal Aortic Aneurysms in High Risk Patients |
Estimated Enrollment: | 400 |
Study Start Date: | September 1998 |
Estimated Study Completion Date: | December 2020 |
Estimated Primary Completion Date: | December 2020 (Final data collection date for primary outcome measure) |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Nancy P Simpson | 216-444-9729 | simpson@ccf.org |
United States, Ohio | |
Cleveland Clinic | Recruiting |
Cleveland, Ohio, United States, 44195 | |
Sub-Investigator: Dan Clair, MD | |
Sub-Investigator: Sean Lyden, MD | |
Sub-Investigator: Sunita Srivastava, MD | |
Sub-Investigator: Matthew Eagleton, MD | |
Sub-Investigator: Eric Roselli, MD | |
Sub-Investigator: Tara Mastracci, MD |
Principal Investigator: | Roy K Greenberg, MD | Cleveland Clinic |
Responsible Party: | Cleveland Clinic ( Roy Greenberg ) |
Study ID Numbers: | G980198, IRB 3264 |
Study First Received: | December 20, 2007 |
Last Updated: | November 5, 2008 |
ClinicalTrials.gov Identifier: | NCT00583414 |
Health Authority: | United States: Food and Drug Administration |
Aortic Diseases Aneurysm Aortic Aneurysm, Abdominal Abdominal aortic aneurysm |
Vascular Diseases Iliac Aneurysm Aortic Aneurysm |
Cardiovascular Diseases |